The Medicines Evaluation Board (MEB) and the Central Committee on Research Involving Human Subjects (CCMO) invite you to the Science Day 2026. This year’s focus is on N-of-1 individualized therapies and how these highly tailored treatments can be responsibly brought to patients.
The event will take place on Wednesday 20 May 2026, from 12:00 to 18:00 at Neude 11, Utrecht. The Science Day will also be live broadcasted. A link to the broadcast will be shared on this website a few days in advance.
Why N-of-1 individuealized therapies?
Recent developments in individualized medicine have challenged traditional approaches to the development, evaluation, and regulation of therapies. High-profile examples such as milasen and other N-of-1 treatments, including the case of Baby KJ, illustrate both the potential of highly tailored therapies and the complexity of bringing them responsibly to patients within existing regulatory and healthcare frameworks.
We will explore international experiences and current developments in the Netherlands, including antisense oligonucleotide treatments and advanced therapy medicinal products (ATMPs).
The programme will also feature the launch of the European Medicines Regulatory Database (EMRD), a new platform developed by Utrecht University and the MEB to improve accessibility and reuse of regulatory information on European medicines.
Poster sessions, panel discussion and networking opportunities
Through presentations, posters, and an interactive panel discussion, we will discuss the challenges faced by clinicians and researchers and reflect on the steps needed towards a roadmap for N-of-1 therapies in the Netherlands.
We look forward to welcoming you on 20 May 2026 in Utrecht! Registration is open (for the livestream, registration is not required):